General Information of the Compound
| Compound ID |
CP0562830
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[3-[(1S,3S,4S,7S,9S)-3,9-dimethyl-9-[3-(pyridine-3-carbonylamino)phenyl]-2,5,8-trioxa-10-azatricyclo[5.2.1.04,10]decan-3-yl]phenyl]pyridine-3-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C32H29N5O5
|
||||||||||||||||||
| Molecular Weight |
563.614
|
||||||||||||||||||
| Canonical SMILES |
C[C@]1(O[C@H]2CO[C@@H]3N2[C@H]1O[C@@]3(C)c1cccc(NC(=O)c2cccnc2)c1)c1cccc(NC(=O)c2cccnc2)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C32H29N5O5/c1-31(22-9-3-11-24(15-22)35-27(38)20-7-5-13-33-17-20)29-37-26(19-40-29)41-32(2,30(37)42-31)23-10-4-12-25(16-23)36-28(39)21-8-6-14-34-18-21/h3-18,26,29-30H,19H2,1-2H3,(H,35,38)(H,36,39)/t26-,29-,30-,31-,32-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
GCTCPNHMOPKFIC-LJEIBCANSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01132, Orexin receptor type 2
Protein ID: PT02001, Orexin/Hypocretin receptor type 1